The physiological role of opioid neurotransmission remains unclear. Part of this lack of clarity is due to uncertainties concerning the volume of extracellular space through which opioid peptides must diffuse to reach their receptors. For a variety of reasons it now seems that the classical concept of the synapse is not an appropriate model in which to explore the physiological role of opioids. Most importantly, it is very unlikely that the active zone of presynaptic nerve terminals (the site from which """"""""classical"""""""" transmitters are released by exocytosis) can be the site from which opioids are released. The purpose of this proposal is to determine at the cellular and subcellular level the sites at which opioid peptides are released from axons. Classical, small molecule neurotransmitters are stored in small synaptic vesicles; the opioids and other neuropeptides are preferentially stored in large granular vesicles. Independent mechanisms exist which are responsible for intracellular trafficking and exocytosis of these two populations of vesicles. In this proposal, experiments are proposed which will determine the spatial occurrence of molecules directly involved in the release of large granular vesicles. The following studies will be conducted: 1. The spatial occurrence of N- and L-types of calcium channels within the membranes of opioidergic nerve fibers in model neuronal systems will be determined using fluorescently-labeled omegaconotoxin, nisoldipine and funnel web spider toxin omega-Aga-IIIA. 2. The spatial occurrence of the alpha1 subunit of the rat brain L-type of calcium channel within the membranes of opioidergic nerve fibers in the mouse vas deferens and the enteric nervous system of the guinea pig ileum will be determined using antibodies selective for peptide sequences of this subunit. 3. The spatial occurrence of calpactin, the putative docking protein for large granular vesicles, will be localized with respect to opioidergic nerve fibers and terminals in the model neural systems. 4. Certain small GTP-binding proteins will be localized with respect to opioidergic nerve fibers, since it is likely that at least one member of this family is crucial in the final stages of large granular vesicle fusion and release.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA008131-05
Application #
6237946
Study Section
Project Start
1997-03-10
Project End
1998-02-28
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Kawai, Hideki; Raftery, Michael A (2010) Kinetics of agonist-induced intrinsic fluorescence changes in the Torpedo acetylcholine receptor. J Biochem 147:743-9
Kawai, Hideki; Dunn, Susan M J; Raftery, Michael A (2008) Epibatidine binds to four sites on the Torpedo nicotinic acetylcholine receptor. Biochem Biophys Res Commun 366:834-9
Carter, Chris R J; Cao, Liren; Kawai, Hideki et al. (2007) Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor. Biochem Pharmacol 73:417-26
Conti-Fine, B M; Navaneetham, D; Lei, S et al. (2000) Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 393:279-94
Bollweg, G L; Sparber, S B (1999) Voltage associated with spontaneous embryonic motility in the developing chicken: an automated characterization during mid-late embryogenesis. Dev Psychobiol 34:5-19
Kawai, H; Carlson, B J; Okita, D K et al. (1999) Eserine and other tertiary amine interactions with Torpedo acetylcholine receptor postsynaptic membrane vesicles. Biochemistry 38:134-41
Wei, L N; Chang, L; HU, X (1999) Studies of the type I cellular retinoic acid-binding protein mutants and their biological activities. Mol Cell Biochem 200:69-76
Schrott, L M; Sweeney, W A; Bodensteiner, K E et al. (1999) Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks. Pharmacol Biochem Behav 64:81-8
Macklin, K D; Conti-Fine, B M (1998) Binding of single substituted promiscuous and designer peptides to purified DRB1*0101. Biochem Biophys Res Commun 242:322-6
Bollweg, G; Wei, Y X; Sparber, S B (1998) Behavioral and neuroendocrine assessment of ritanserin exposure in the developing chicken: lack of toxicity at effective doses. Pharmacol Biochem Behav 60:175-81

Showing the most recent 10 out of 50 publications